LABORATORY RESEARCH Cell of Origin in AML: Susceptibility to MN1-Induced Transformation Is Regulated by the MEIS1/AbdB-Like HOX Protein Complex Scientists characterized the cell of origin and its critical pathways in MN1-induced leukemias. [Cancer Cell] Tumor Necrosis Factor Restricts Hematopoietic Stem Cell Activity in Mice: Involvement of Two Distinct Receptors Researchers demonstrate that tumor necrosis factor-α is a cell-extrinsic and potent endogenous suppressor of normal hematopoietic stem cell activity in vivo in mice. [J Exp Med] Translational Repression of p53 by RNPC1, a p53 Target Overexpressed in Lymphomas Scientists identified RNPC1, a p53 target and a RNA-binding protein, as a critical regulator of p53 translation. [Genes Dev] MSI2 Protein Expression Predicts Unfavorable Outcome in Acute Myeloid Leukemia In order to test MSI2 as a new prognostic marker, researchers measured MSI2 protein level by immunohistochemistry in 120 AML patients. [Blood] Deletion of Genes Encoding PU.1 and Spi-B in B Cells Impairs Differentiation and Induces Pre-B Cell Acute Lymphoblastic Leukemia Investigators hypothesized that PU.1 function in B cell differentiation is complemented by the related E26-transformation specific transcription factor Spi-B. [Blood] Differential Niche and Wnt Requirements During Acute Myeloid Leukemia Progression Scientists used a syngeneic retroviral model of MLL-AF9 induced acute myeloid leukemia to evaluate leukemia stem cell-microenvironment interactions in vivo. [Blood] Gene Expression Profiling in the Leukemic Stem Cell-Enriched CD34+ Fraction Identifies Target Genes That Predict Prognosis in Normal Karyotype AML In order to identify acute myeloid leukemia (AML) CD34+-specific gene expression profiles, mononuclear cells from AML patients (n=46) were sorted into CD34+ and CD34− subfractions, and genome-wide expression analysis was performed using Illumina BeadChip Arrays. [Leukemia] Gfer Is a Critical Regulator of HSC Proliferation Researchers extended their study to demonstrate an association between growth factor erv1-like (Gfer) and Ca2+/calmodulin-dependent protein kinase IV in the regulation of hematopoietic stem cell (HSC) proliferation. [Cell Cycle] HOXA4 Induces Expansion of Hematopoietic Stem Cells In Vitro and Confers Enhancement of Pro-B-Cells In Vivo Investigators measured the ability of HOXA4 to promote ex vivo expansion of hematopoietic stem cells and progenitors using retroviral mediated overexpression. [Stem Cells Dev] CLINICAL RESEARCH Acceptable HLA-Mismatching in Unrelated Donor Bone Marrow Transplantation for Patients with Acquired Severe Aplastic Anemia Scientists retrospectively analyzed the impact of HLA mismatching (HLA-A, -B, -C, -DRB1, -DQB1) using molecular typing on transplant outcome for 301 patients with acquired severe aplastic anemia who received unrelated bone marrow transplantation through the Japan Marrow Donor Program. [Blood] Hematopoietic Stem Cell Transplantation for CD3δ Deficiency The objective of this study is to study the outcome of CD3δ deficiency by using various modalities of stem cell transplantation. [J Allergy Clin Immunol] AAML03P1, a Pilot Study of the Safety of Gemtuzumab Ozogamicin in Combination with Chemotherapy for Newly Diagnosed Childhood Acute Myeloid Leukemia The Children’s Oncology Group AAML03P1 trial sought to determine the safety of adding 2 doses of gemtuzumab ozogamicin, a humanized anti-CD33 antibody-targeted agent, to intensive chemotherapy during remission induction and postremission intensification for children with de novo acute myeloid leukemia. [Cancer] |